Structure

Physi-Chem Properties

Molecular Weight:  442.24
Volume:  466.869
LogP:  4.898
LogD:  3.852
LogS:  -4.049
# Rotatable Bonds:  9
TPSA:  96.22
# H-Bond Aceptor:  6
# H-Bond Donor:  3
# Rings:  3
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.456
Synthetic Accessibility Score:  3.49
Fsp3:  0.5
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.813
MDCK Permeability:  1.680978311924264e-05
Pgp-inhibitor:  0.656
Pgp-substrate:  0.002
Human Intestinal Absorption (HIA):  0.01
20% Bioavailability (F20%):  0.026
30% Bioavailability (F30%):  0.008

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.043
Plasma Protein Binding (PPB):  98.13550567626953%
Volume Distribution (VD):  0.604
Pgp-substrate:  1.0853300094604492%

ADMET: Metabolism

CYP1A2-inhibitor:  0.704
CYP1A2-substrate:  0.895
CYP2C19-inhibitor:  0.676
CYP2C19-substrate:  0.097
CYP2C9-inhibitor:  0.547
CYP2C9-substrate:  0.951
CYP2D6-inhibitor:  0.877
CYP2D6-substrate:  0.897
CYP3A4-inhibitor:  0.756
CYP3A4-substrate:  0.286

ADMET: Excretion

Clearance (CL):  9.226
Half-life (T1/2):  0.82

ADMET: Toxicity

hERG Blockers:  0.046
Human Hepatotoxicity (H-HT):  0.208
Drug-inuced Liver Injury (DILI):  0.037
AMES Toxicity:  0.089
Rat Oral Acute Toxicity:  0.057
Maximum Recommended Daily Dose:  0.354
Skin Sensitization:  0.919
Carcinogencity:  0.137
Eye Corrosion:  0.003
Eye Irritation:  0.042
Respiratory Toxicity:  0.063

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC472963

Natural Product ID:  NPC472963
Common Name*:   KMZMDRKKQBTDEX-UHFFFAOYSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  KMZMDRKKQBTDEX-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C26H34O6/c1-25(2,31-4)13-5-14-26(3)15-12-19-17(7-11-22(29)24(19)32-26)6-10-21(28)20-9-8-18(27)16-23(20)30/h7-9,11,16,27,29-30H,5-6,10,12-15H2,1-4H3
SMILES:  CC1(CCC2=C(C=CC(=C2O1)O)CCC(=O)C3=C(C=C(C=C3)O)O)CCCC(C)(C)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3594223
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0003467] Linear 1,3-diarylpropanoids
        • [CHEMONTID:0001630] Chalcones and dihydrochalcones
          • [CHEMONTID:0003473] 2'-Hydroxy-dihydrochalcones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33150 Artocarpus communis Species Moraceae Eukaryota heartwood n.a. n.a. PMID[16643064]
NPO28799 Hyptis suaveolens Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[19299148]
NPO33150 Artocarpus communis Species Moraceae Eukaryota roots Khon Kaen, Thailand 2009-DEC PMID[25537111]
NPO33150 Artocarpus communis Species Moraceae Eukaryota n.a. n.a. n.a. PMID[26178912]
NPO28799 Hyptis suaveolens Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[26178912]
NPO28799 Hyptis suaveolens Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO28799 Hyptis suaveolens Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO28799 Hyptis suaveolens Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO28799 Hyptis suaveolens Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 48300.0 nM PMID[489568]
NPT610 Others Molecular identity unknown IC50 = 39900.0 nM PMID[489568]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC472963 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9933 High Similarity NPC472907
0.9799 High Similarity NPC472905
0.9739 High Similarity NPC472964
0.9737 High Similarity NPC474960
0.9608 High Similarity NPC472902
0.9605 High Similarity NPC136674
0.9542 High Similarity NPC476242
0.9539 High Similarity NPC24640
0.9536 High Similarity NPC469550
0.9487 High Similarity NPC293319
0.9484 High Similarity NPC201800
0.9481 High Similarity NPC36217
0.9481 High Similarity NPC471973
0.9477 High Similarity NPC129684
0.9477 High Similarity NPC241904
0.9477 High Similarity NPC67876
0.9477 High Similarity NPC299520
0.9477 High Similarity NPC300727
0.9474 High Similarity NPC152951
0.9474 High Similarity NPC117992
0.9474 High Similarity NPC230149
0.9474 High Similarity NPC57674
0.9474 High Similarity NPC256925
0.9474 High Similarity NPC67396
0.9474 High Similarity NPC168247
0.9474 High Similarity NPC234255
0.947 High Similarity NPC260979
0.947 High Similarity NPC472912
0.947 High Similarity NPC477231
0.947 High Similarity NPC257648
0.9467 High Similarity NPC151473
0.9467 High Similarity NPC29231
0.9427 High Similarity NPC39091
0.9423 High Similarity NPC186686
0.9419 High Similarity NPC278052
0.9419 High Similarity NPC61010
0.9419 High Similarity NPC40491
0.9419 High Similarity NPC472906
0.9416 High Similarity NPC204879
0.9416 High Similarity NPC210459
0.9416 High Similarity NPC55738
0.9416 High Similarity NPC235448
0.9412 High Similarity NPC274730
0.9412 High Similarity NPC472455
0.9408 High Similarity NPC49402
0.9408 High Similarity NPC70433
0.9408 High Similarity NPC227337
0.9408 High Similarity NPC273462
0.9408 High Similarity NPC33051
0.9408 High Similarity NPC18727
0.9404 High Similarity NPC31363
0.9367 High Similarity NPC218226
0.9363 High Similarity NPC303174
0.9363 High Similarity NPC239752
0.9363 High Similarity NPC275780
0.9363 High Similarity NPC472450
0.9355 High Similarity NPC200746
0.9355 High Similarity NPC228785
0.9355 High Similarity NPC14353
0.9355 High Similarity NPC56085
0.9355 High Similarity NPC139036
0.9355 High Similarity NPC470183
0.9355 High Similarity NPC299436
0.9355 High Similarity NPC321399
0.9355 High Similarity NPC320359
0.9351 High Similarity NPC218313
0.9351 High Similarity NPC291508
0.9351 High Similarity NPC474681
0.9351 High Similarity NPC52889
0.9351 High Similarity NPC180011
0.9351 High Similarity NPC27337
0.9351 High Similarity NPC161960
0.9351 High Similarity NPC304008
0.9351 High Similarity NPC187745
0.9351 High Similarity NPC219867
0.9351 High Similarity NPC111969
0.9346 High Similarity NPC472280
0.9346 High Similarity NPC31018
0.9346 High Similarity NPC255807
0.9342 High Similarity NPC39732
0.9342 High Similarity NPC302950
0.9342 High Similarity NPC237994
0.9342 High Similarity NPC219582
0.9342 High Similarity NPC236637
0.9342 High Similarity NPC60972
0.9338 High Similarity NPC85131
0.9333 High Similarity NPC196277
0.9333 High Similarity NPC272721
0.9333 High Similarity NPC43669
0.9304 High Similarity NPC43319
0.9304 High Similarity NPC477517
0.9299 High Similarity NPC236521
0.9299 High Similarity NPC7483
0.9299 High Similarity NPC189473
0.9299 High Similarity NPC248638
0.9299 High Similarity NPC23298
0.9299 High Similarity NPC152659
0.9299 High Similarity NPC475985
0.9299 High Similarity NPC236132
0.9299 High Similarity NPC220313
0.9295 High Similarity NPC472634
0.9295 High Similarity NPC234644
0.9295 High Similarity NPC57715
0.9295 High Similarity NPC471210
0.9295 High Similarity NPC474187
0.929 High Similarity NPC474290
0.929 High Similarity NPC100123
0.929 High Similarity NPC280680
0.929 High Similarity NPC184755
0.929 High Similarity NPC74178
0.9286 High Similarity NPC115853
0.9286 High Similarity NPC35038
0.9286 High Similarity NPC278778
0.9286 High Similarity NPC470600
0.9286 High Similarity NPC133970
0.9286 High Similarity NPC474638
0.9286 High Similarity NPC209614
0.9286 High Similarity NPC195796
0.9286 High Similarity NPC6633
0.9286 High Similarity NPC472916
0.9286 High Similarity NPC5322
0.9286 High Similarity NPC472626
0.9286 High Similarity NPC470328
0.9286 High Similarity NPC291878
0.9281 High Similarity NPC88645
0.9281 High Similarity NPC89474
0.9281 High Similarity NPC271779
0.9281 High Similarity NPC206238
0.9281 High Similarity NPC167091
0.9281 High Similarity NPC141212
0.9281 High Similarity NPC292214
0.9276 High Similarity NPC154345
0.9272 High Similarity NPC183950
0.9272 High Similarity NPC177298
0.9272 High Similarity NPC137062
0.9272 High Similarity NPC48479
0.9272 High Similarity NPC52005
0.9272 High Similarity NPC287101
0.9272 High Similarity NPC223579
0.9272 High Similarity NPC105512
0.9267 High Similarity NPC95864
0.9267 High Similarity NPC77378
0.9241 High Similarity NPC475888
0.9236 High Similarity NPC83922
0.9236 High Similarity NPC474150
0.9236 High Similarity NPC329760
0.9236 High Similarity NPC472448
0.9236 High Similarity NPC474162
0.9236 High Similarity NPC25152
0.9236 High Similarity NPC229632
0.9236 High Similarity NPC211107
0.9236 High Similarity NPC474034
0.9236 High Similarity NPC474033
0.9231 High Similarity NPC119209
0.9231 High Similarity NPC474287
0.9231 High Similarity NPC472624
0.9231 High Similarity NPC472631
0.9231 High Similarity NPC472630
0.9231 High Similarity NPC192686
0.9231 High Similarity NPC475886
0.9231 High Similarity NPC118256
0.9231 High Similarity NPC188433
0.9231 High Similarity NPC476980
0.9226 High Similarity NPC472911
0.9226 High Similarity NPC156057
0.9226 High Similarity NPC471515
0.9226 High Similarity NPC474208
0.9226 High Similarity NPC273843
0.9226 High Similarity NPC162869
0.9226 High Similarity NPC236796
0.9226 High Similarity NPC78225
0.9226 High Similarity NPC165977
0.9226 High Similarity NPC217677
0.9226 High Similarity NPC472914
0.9226 High Similarity NPC99597
0.9226 High Similarity NPC471479
0.9226 High Similarity NPC48208
0.9226 High Similarity NPC472598
0.9226 High Similarity NPC262286
0.9226 High Similarity NPC210084
0.9226 High Similarity NPC475267
0.9226 High Similarity NPC36852
0.9226 High Similarity NPC181960
0.9226 High Similarity NPC474836
0.9226 High Similarity NPC472910
0.9226 High Similarity NPC96167
0.9226 High Similarity NPC245758
0.9226 High Similarity NPC474055
0.9226 High Similarity NPC469584
0.9226 High Similarity NPC472913
0.9226 High Similarity NPC222814
0.9226 High Similarity NPC52530
0.9221 High Similarity NPC226025
0.9221 High Similarity NPC470327
0.9221 High Similarity NPC20541
0.9221 High Similarity NPC477503
0.9221 High Similarity NPC2928
0.9221 High Similarity NPC256612
0.9221 High Similarity NPC45849
0.9221 High Similarity NPC200761

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC472963 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9342 High Similarity NPD1934 Approved
0.9156 High Similarity NPD2801 Approved
0.9156 High Similarity NPD2393 Clinical (unspecified phase)
0.9038 High Similarity NPD3882 Suspended
0.894 High Similarity NPD1511 Approved
0.8882 High Similarity NPD6166 Phase 2
0.8882 High Similarity NPD6167 Clinical (unspecified phase)
0.8882 High Similarity NPD6168 Clinical (unspecified phase)
0.8824 High Similarity NPD1512 Approved
0.879 High Similarity NPD7819 Suspended
0.878 High Similarity NPD7074 Phase 3
0.872 High Similarity NPD7054 Approved
0.8667 High Similarity NPD7472 Approved
0.8659 High Similarity NPD3818 Discontinued
0.8625 High Similarity NPD7075 Discontinued
0.8616 High Similarity NPD3817 Phase 2
0.8609 High Similarity NPD1549 Phase 2
0.8598 High Similarity NPD7473 Discontinued
0.8562 High Similarity NPD4868 Clinical (unspecified phase)
0.8553 High Similarity NPD1465 Phase 2
0.8553 High Similarity NPD7096 Clinical (unspecified phase)
0.8543 High Similarity NPD1552 Clinical (unspecified phase)
0.8543 High Similarity NPD1550 Clinical (unspecified phase)
0.8528 High Similarity NPD6232 Discontinued
0.8519 High Similarity NPD5494 Approved
0.8516 High Similarity NPD4378 Clinical (unspecified phase)
0.8481 Intermediate Similarity NPD4380 Phase 2
0.8452 Intermediate Similarity NPD7251 Discontinued
0.8411 Intermediate Similarity NPD1510 Phase 2
0.8402 Intermediate Similarity NPD7808 Phase 3
0.8397 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8395 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8393 Intermediate Similarity NPD6797 Phase 2
0.8389 Intermediate Similarity NPD1240 Approved
0.8385 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8383 Intermediate Similarity NPD5844 Phase 1
0.8355 Intermediate Similarity NPD2796 Approved
0.8333 Intermediate Similarity NPD6799 Approved
0.8294 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8282 Intermediate Similarity NPD3749 Approved
0.8278 Intermediate Similarity NPD1607 Approved
0.8267 Intermediate Similarity NPD943 Approved
0.8258 Intermediate Similarity NPD3750 Approved
0.825 Intermediate Similarity NPD6599 Discontinued
0.8247 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8242 Intermediate Similarity NPD6959 Discontinued
0.8199 Intermediate Similarity NPD7411 Suspended
0.8148 Intermediate Similarity NPD6801 Discontinued
0.8144 Intermediate Similarity NPD3926 Phase 2
0.8117 Intermediate Similarity NPD6100 Approved
0.8117 Intermediate Similarity NPD6099 Approved
0.807 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8059 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8011 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD7768 Phase 2
0.8 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7988 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.795 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7935 Intermediate Similarity NPD3748 Approved
0.7935 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7933 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7919 Intermediate Similarity NPD6559 Discontinued
0.7917 Intermediate Similarity NPD7199 Phase 2
0.7908 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7908 Intermediate Similarity NPD1613 Approved
0.7904 Intermediate Similarity NPD919 Approved
0.784 Intermediate Similarity NPD5403 Approved
0.7831 Intermediate Similarity NPD5402 Approved
0.7826 Intermediate Similarity NPD2533 Approved
0.7826 Intermediate Similarity NPD2532 Approved
0.7826 Intermediate Similarity NPD2534 Approved
0.7824 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7821 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7811 Intermediate Similarity NPD1247 Approved
0.7809 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7799 Intermediate Similarity NPD4628 Phase 3
0.7799 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7791 Intermediate Similarity NPD3751 Discontinued
0.7778 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD1551 Phase 2
0.7771 Intermediate Similarity NPD2935 Discontinued
0.7744 Intermediate Similarity NPD3226 Approved
0.7742 Intermediate Similarity NPD230 Phase 1
0.7742 Intermediate Similarity NPD1933 Approved
0.7742 Intermediate Similarity NPD447 Suspended
0.774 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7736 Intermediate Similarity NPD2800 Approved
0.7736 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7722 Intermediate Similarity NPD2344 Approved
0.7722 Intermediate Similarity NPD2346 Discontinued
0.7722 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7716 Intermediate Similarity NPD5401 Approved
0.7712 Intermediate Similarity NPD3027 Phase 3
0.7692 Intermediate Similarity NPD6234 Discontinued
0.7667 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7661 Intermediate Similarity NPD3787 Discontinued
0.7654 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7597 Intermediate Similarity NPD4625 Phase 3
0.7595 Intermediate Similarity NPD2799 Discontinued
0.7586 Intermediate Similarity NPD7228 Approved
0.7582 Intermediate Similarity NPD9494 Approved
0.758 Intermediate Similarity NPD6651 Approved
0.7546 Intermediate Similarity NPD7390 Discontinued
0.7532 Intermediate Similarity NPD4908 Phase 1
0.7531 Intermediate Similarity NPD2309 Approved
0.7528 Intermediate Similarity NPD8313 Approved
0.7528 Intermediate Similarity NPD8312 Approved
0.7516 Intermediate Similarity NPD1243 Approved
0.7514 Intermediate Similarity NPD7685 Pre-registration
0.75 Intermediate Similarity NPD37 Approved
0.7472 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7471 Intermediate Similarity NPD4965 Approved
0.7471 Intermediate Similarity NPD4967 Phase 2
0.7471 Intermediate Similarity NPD4966 Approved
0.747 Intermediate Similarity NPD1653 Approved
0.7469 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7458 Intermediate Similarity NPD5953 Discontinued
0.7451 Intermediate Similarity NPD1203 Approved
0.7443 Intermediate Similarity NPD7286 Phase 2
0.7436 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7423 Intermediate Similarity NPD6190 Approved
0.7419 Intermediate Similarity NPD6832 Phase 2
0.7417 Intermediate Similarity NPD1610 Phase 2
0.7417 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.741 Intermediate Similarity NPD920 Approved
0.7403 Intermediate Similarity NPD8150 Discontinued
0.7403 Intermediate Similarity NPD2798 Approved
0.7403 Intermediate Similarity NPD8434 Phase 2
0.7378 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7356 Intermediate Similarity NPD5711 Approved
0.7356 Intermediate Similarity NPD5710 Approved
0.734 Intermediate Similarity NPD6779 Approved
0.734 Intermediate Similarity NPD6780 Approved
0.734 Intermediate Similarity NPD6781 Approved
0.734 Intermediate Similarity NPD6782 Approved
0.734 Intermediate Similarity NPD6777 Approved
0.734 Intermediate Similarity NPD6778 Approved
0.734 Intermediate Similarity NPD6776 Approved
0.7338 Intermediate Similarity NPD1470 Approved
0.7325 Intermediate Similarity NPD2313 Discontinued
0.7325 Intermediate Similarity NPD3764 Approved
0.7325 Intermediate Similarity NPD3268 Approved
0.7322 Intermediate Similarity NPD4287 Approved
0.7321 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.732 Intermediate Similarity NPD4749 Approved
0.7316 Intermediate Similarity NPD7435 Discontinued
0.7314 Intermediate Similarity NPD5242 Approved
0.731 Intermediate Similarity NPD4288 Approved
0.7306 Intermediate Similarity NPD8151 Discontinued
0.7303 Intermediate Similarity NPD1201 Approved
0.7289 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7289 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7289 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD7033 Discontinued
0.7267 Intermediate Similarity NPD4308 Phase 3
0.7257 Intermediate Similarity NPD7229 Phase 3
0.7255 Intermediate Similarity NPD9717 Approved
0.7255 Intermediate Similarity NPD1608 Approved
0.7233 Intermediate Similarity NPD4060 Phase 1
0.7226 Intermediate Similarity NPD2797 Approved
0.7225 Intermediate Similarity NPD7698 Approved
0.7225 Intermediate Similarity NPD7696 Phase 3
0.7225 Intermediate Similarity NPD7697 Approved
0.7222 Intermediate Similarity NPD5405 Approved
0.7222 Intermediate Similarity NPD5404 Approved
0.7222 Intermediate Similarity NPD5406 Approved
0.7222 Intermediate Similarity NPD5408 Approved
0.7219 Intermediate Similarity NPD7458 Discontinued
0.7215 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7209 Intermediate Similarity NPD5353 Approved
0.7202 Intermediate Similarity NPD7584 Approved
0.72 Intermediate Similarity NPD5536 Phase 2
0.7188 Intermediate Similarity NPD7871 Phase 2
0.7188 Intermediate Similarity NPD6355 Discontinued
0.7188 Intermediate Similarity NPD7870 Phase 2
0.7188 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7178 Intermediate Similarity NPD1471 Phase 3
0.7175 Intermediate Similarity NPD2403 Approved
0.7173 Intermediate Similarity NPD6823 Phase 2
0.7166 Intermediate Similarity NPD4360 Phase 2
0.7166 Intermediate Similarity NPD4363 Phase 3
0.7165 Intermediate Similarity NPD7701 Phase 2
0.7152 Intermediate Similarity NPD8166 Discontinued
0.7152 Intermediate Similarity NPD1548 Phase 1
0.7152 Intermediate Similarity NPD7095 Approved
0.7143 Intermediate Similarity NPD3972 Approved
0.7143 Intermediate Similarity NPD7783 Phase 2
0.7143 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD9269 Phase 2
0.7135 Intermediate Similarity NPD6386 Approved
0.7135 Intermediate Similarity NPD6385 Approved
0.7134 Intermediate Similarity NPD3018 Phase 2
0.7127 Intermediate Similarity NPD7240 Approved
0.7126 Intermediate Similarity NPD4357 Discontinued
0.711 Intermediate Similarity NPD5978 Approved
0.711 Intermediate Similarity NPD5977 Approved
0.7108 Intermediate Similarity NPD2354 Approved
0.7107 Intermediate Similarity NPD6798 Discontinued
0.7107 Intermediate Similarity NPD411 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data